001     138488
005     20240321220441.0
024 7 _ |a 10.1001/jamaneurol.2015.4791
|2 doi
024 7 _ |a pmid:26882076
|2 pmid
024 7 _ |a 0003-9942
|2 ISSN
024 7 _ |a 0375-8540
|2 ISSN
024 7 _ |a 1538-3687
|2 ISSN
024 7 _ |a 2168-6149
|2 ISSN
024 7 _ |a 2168-6157
|2 ISSN
024 7 _ |a 2330-9644
|2 ISSN
024 7 _ |a altmetric:5612817
|2 altmetric
037 _ _ |a DZNE-2020-04810
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Gomm, Willy
|0 P:(DE-2719)2811376
|b 0
|e First author
245 _ _ |a Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
260 _ _ |a Chicago, Ill.
|c 2016
|b American Medical Association
264 _ 1 |3 print
|2 Crossref
|b American Medical Association (AMA)
|c 2016-04-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1589289426_25757
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Proton Pump Inhibitors
|2 NLM Chemicals
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Cohort Studies
|2 MeSH
650 _ 2 |a Dementia: chemically induced
|2 MeSH
650 _ 2 |a Dementia: diagnosis
|2 MeSH
650 _ 2 |a Dementia: epidemiology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Insurance Claim Review: statistics & numerical data
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Pharmacoepidemiology: methods
|2 MeSH
650 _ 2 |a Pharmacoepidemiology: statistics & numerical data
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Proton Pump Inhibitors: adverse effects
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
700 1 _ |a von Holt, Klaus
|0 P:(DE-2719)2810710
|b 1
|u dzne
700 1 _ |a Thomé, Friederike
|0 P:(DE-2719)2810705
|b 2
700 1 _ |a Broich, Karl
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Maier, Wolfgang
|0 P:(DE-2719)2000015
|b 4
700 1 _ |a Fink, Anne
|0 P:(DE-2719)2241493
|b 5
700 1 _ |a Doblhammer-Reiter, Gabriele
|0 P:(DE-2719)2811246
|b 6
700 1 _ |a Haenisch, Britta
|0 P:(DE-2719)2810511
|b 7
|e Last author
773 1 8 |a 10.1001/jamaneurol.2015.4791
|b : American Medical Association (AMA), 2016-04-01
|n 4
|p 410
|3 journal-article
|2 Crossref
|t JAMA Neurology
|v 73
|y 2016
|x 2168-6149
773 _ _ |a 10.1001/jamaneurol.2015.4791
|g Vol. 73, no. 4, p. 410 -
|0 PERI:(DE-600)2701924-X
|n 4
|q 73:4<410 -
|p 410
|t JAMA neurology
|v 73
|y 2016
|x 2168-6149
909 C O |o oai:pub.dzne.de:138488
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811376
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810710
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2810705
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2000015
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2241493
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2811246
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2810511
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2016
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JAMA NEUROL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b JAMA NEUROL : 2017
920 1 _ |0 I:(DE-2719)1013010
|k AG Hänisch
|l Pharmacoepidemiology in Neurodegenerative Disorders
|x 0
920 1 _ |0 I:(DE-2719)7000001
|k U Clinical Researchers - Bonn
|l U Clinical Researchers - Bonn
|x 1
920 1 _ |0 I:(DE-2719)1012002
|k AG Doblhammer-Reiter
|l Demographic Studies
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1013010
980 _ _ |a I:(DE-2719)7000001
980 _ _ |a I:(DE-2719)1012002
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21